{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:54:54Z","timestamp":1648529694813},"reference-count":20,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ajg.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T19:50:46Z","timestamp":1446234646000},"page":"125-128","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatment"],"prefix":"10.1016","volume":"16","author":[{"given":"Eslam Saber","family":"Esmail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fat-heyah Elsayed","family":"Asal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Yussif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asem Ahmed","family":"Elfert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ajg.2015.09.012_b0005","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajg.2015.09.012_b0010","first-page":"47","article-title":"Hepatitis C infection in Iran; a review article","volume":"4","author":"Alavian","year":"2009","journal-title":"Iran J Clin Infect Dis"},{"issue":"Suppl.","key":"10.1016\/j.ajg.2015.09.012_b0015","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1046\/j.1440-1746.2000.02134.x","article-title":"Public health challenges in hepatitis C virus infection","volume":"15","author":"Kaldor","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.ajg.2015.09.012_b0020","first-page":"S18","article-title":"Public health and hepatitis C","volume":"91","author":"Patrick","year":"2000","journal-title":"Can J Public Health"},{"issue":"1","key":"10.1016\/j.ajg.2015.09.012_b0025","first-page":"19","article-title":"Screening of health care workers for hepatitis B virus and hepatitis C virus: criteria for fitness for work (abstract)","volume":"51","author":"Prati","year":"2000","journal-title":"Arh Hig Rada Toksikol"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.012_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1542-4758.2010.00437.x","article-title":"Hepatitis C infection in hemodialysis patients in Iran: a systematic review","volume":"14","author":"Alavian","year":"2010","journal-title":"Hemodial Int"},{"key":"10.1016\/j.ajg.2015.09.012_b0035","series-title":"Egypt Demographic and Health Survey 2008","author":"El-Zanaty","year":"2009"},{"issue":"2","key":"10.1016\/j.ajg.2015.09.012_b0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"13","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ajg.2015.09.012_b0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.26719\/2009.15.3.692","article-title":"Skin manifestations of chronic HCV infection in Cairo","volume":"15","author":"Raslan","year":"2009","journal-title":"Egypt East Mediterr Health J"},{"key":"10.1016\/j.ajg.2015.09.012_b0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10years experience of the dermatology life quality index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.ajg.2015.09.012_b0055","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2015.09.012_b0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/gast.2000.17936","article-title":"High incidence of oral lichen planus in an HCV hyperendemic area","volume":"119","author":"Nagao","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajg.2015.09.012_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/jhep.2000.8533","article-title":"Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus","volume":"32","author":"Arrieta","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2015.09.012_b0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-4362.2000.00903.x","article-title":"Oral lichen planus: different clinical features in HCV-positive and HCV negative patients","volume":"39","author":"Mignogna","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ajg.2015.09.012_b0075","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nature03153","article-title":"Modelling how ribavirin improves interferon response rates in hepatitis C virus infection","volume":"432","author":"Dixit","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ajg.2015.09.012_b0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1572-0241.2006.00505.x","article-title":"Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials","volume":"101","author":"Brok","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajg.2015.09.012_b0085","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-123-12-199512150-00001","article-title":"Ribavirin as therapy for chronic hepatitis C; a randomized, double-blind, placebo-controlled trial","volume":"123","author":"Di Bisceglie","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajg.2015.09.012_b0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.510260231","article-title":"Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial","volume":"26","author":"Bodenheimer","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ajg.2015.09.012_b0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0168-8278(96)80225-X","article-title":"Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study","volume":"25","author":"Dusheiko","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2015.09.012_b0100","unstructured":"Flamm S, Chopra S. Mechanism of action and efficacy of ribavirin for the treatment of chronic hepatitis C virus infection. Up to date CD-ROM 21.2 2012; Topic 3654."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719791500088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S168719791500088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:39:42Z","timestamp":1567298382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S168719791500088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":20,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S168719791500088X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2015.09.012","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatment","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Arab Journal of Gastroenterology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}